These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 21207078

  • 1. In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism.
    Srulijes K, Mallien G, Bauer S, Dietzel E, Gröger A, Ebersbach G, Berg D, Maetzler W.
    J Neural Transm (Vienna); 2011 Aug; 118(8):1191-7. PubMed ID: 21207078
    [Abstract] [Full Text] [Related]

  • 2. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C, Assogna F, Cellupica N, Piras F, Pierantozzi M, Stefani A, Cerroni R, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G.
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [Abstract] [Full Text] [Related]

  • 3. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
    Assogna F, Pellicano C, Cravello L, Savini C, Macchiusi L, Pierantozzi M, Stefani A, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G.
    Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ.
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [Abstract] [Full Text] [Related]

  • 5. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ, Revesz T.
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [Abstract] [Full Text] [Related]

  • 6. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z, Rohan Z, Rusina R, Tesar A, Kukal J, Kovacs GG, Bartos A, Matej R.
    BMC Neurol; 2019 Mar 20; 19(1):42. PubMed ID: 30894142
    [Abstract] [Full Text] [Related]

  • 7. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M, Cuoco S, Tepedino MF, Cappiello A, Volpe G, Erro R, Santangelo G, Pellecchia MT, Barone P, PSP Salerno study group.
    J Neurol; 2019 Jul 20; 266(7):1727-1735. PubMed ID: 30989369
    [Abstract] [Full Text] [Related]

  • 8. Association of PSP phenotypes with survival: A brain-bank study.
    Guasp M, Molina-Porcel L, Painous C, Caballol N, Camara A, Perez-Soriano A, Sánchez-Gómez A, Garrido A, Muñoz E, Marti MJ, Valldeoriola F, Grau O, Gelpí E, Respondek G, Höglinger GH, Compta Y.
    Parkinsonism Relat Disord; 2021 Mar 20; 84():77-81. PubMed ID: 33581485
    [Abstract] [Full Text] [Related]

  • 9. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
    Sitek EJ, Wieczorek D, Konkel A, Dąbrowska M, Sławek J.
    Psychiatr Pol; 2017 Aug 29; 51(4):647-659. PubMed ID: 28987055
    [Abstract] [Full Text] [Related]

  • 10. Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease.
    Pinkhardt EH, Jürgens R, Becker W, Valdarno F, Ludolph AC, Kassubek J.
    J Neurol; 2008 Dec 29; 255(12):1916-25. PubMed ID: 19224319
    [Abstract] [Full Text] [Related]

  • 11. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
    Horta-Barba A, Pagonabarraga J, Martínez-Horta S, Busteed L, Pascual-Sedano B, Illán-Gala I, Marin-Lahoz J, Aracil-Bolaños I, Pérez-Pérez J, Sampedro F, Bejr-Kasem H, Kulisevsky J.
    J Neurol; 2021 Sep 29; 268(9):3400-3408. PubMed ID: 33704556
    [Abstract] [Full Text] [Related]

  • 12. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.
    O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, Revesz T, Lees AJ.
    Brain; 2008 May 29; 131(Pt 5):1362-72. PubMed ID: 18385183
    [Abstract] [Full Text] [Related]

  • 13. Clinical Phenotypes of Progressive Supranuclear Palsy-The Differences in Interleukin Patterns.
    Madetko-Alster N, Otto-Ślusarczyk D, Wiercińska-Drapało A, Koziorowski D, Szlufik S, Samborska-Ćwik J, Struga M, Friedman A, Alster P.
    Int J Mol Sci; 2023 Oct 13; 24(20):. PubMed ID: 37894815
    [Abstract] [Full Text] [Related]

  • 14. Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients.
    dell'Aquila C, Zoccolella S, Cardinali V, de Mari M, Iliceto G, Tartaglione B, Lamberti P, Logroscino G.
    Parkinsonism Relat Disord; 2013 Nov 13; 19(11):980-5. PubMed ID: 23968651
    [Abstract] [Full Text] [Related]

  • 15. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
    Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM.
    Mov Disord; 2011 Feb 01; 26(2):256-63. PubMed ID: 21412832
    [Abstract] [Full Text] [Related]

  • 16. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA.
    Neurodegener Dis; 2008 Feb 01; 5(6):339-46. PubMed ID: 18349518
    [Abstract] [Full Text] [Related]

  • 17. Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy.
    Tommasini L, Bonaccorsi J, Del Prete E, Cintoli S, Pagni C, Mazzucchi S, Palermo G, Morganti R, Frosini D, Siciliano G, Tognoni G, Ceravolo R.
    Clin Neuropsychol; 2023 Aug 01; 37(6):1207-1220. PubMed ID: 35997036
    [Abstract] [Full Text] [Related]

  • 18. Uncovering clinical and radiological asymmetry in progressive supranuclear palsy-Richardson's syndrome.
    Picillo M, Tepedino MF, Abate F, Ponticorvo S, Erro R, Cuoco S, Oksuz N, Di Salle G, Di Salle F, Esposito F, Pellecchia MT, Manara R, Barone P.
    Neurol Sci; 2022 Jun 01; 43(6):3677-3682. PubMed ID: 35106692
    [Abstract] [Full Text] [Related]

  • 19. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M, Tepedino MF, Abate F, Erro R, Ponticorvo S, Tartaglione S, Volpe G, Frosini D, Cecchi P, Cosottini M, Ceravolo R, Esposito F, Pellecchia MT, Barone P, Manara R.
    J Neurol Neurosurg Psychiatry; 2020 Jan 01; 91(1):98-103. PubMed ID: 31527182
    [Abstract] [Full Text] [Related]

  • 20. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.
    Ransmayr L, Fuchs A, Ransmayr-Tepser S, Kommenda R, Kögl M, Schwingenschuh P, Fellner F, Guger M, Eggers C, Darkow R, Mangesius S, Ransmayr G.
    J Neural Transm (Vienna); 2022 Aug 01; 129(8):1039-1048. PubMed ID: 35821453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.